Kilifi Epilepsy Education Program (KEEP): An intervention to reduce the epilepsy treatment gap

Kathomi, Caroline

doi:10.1186/isrctn35680481

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The sum score of this scale is ranged from minimum of 3 to the maximum 14, which is categorized into poor support 3–8, moderate support 9–11, and strong support 12–14 [28]. Felt stigma towards epilepsy was measured by using Kilifi stigma scale of epilepsy and the score above 10 indicated presence of perceived stigma [29]. …”

Section: Methodsmentioning

confidence: 99%

Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy

Getnet¹,

Woldeyohannes

Bekana³

et al. 2016

Behavioural Neurology

View full text Add to dashboard Cite

Introduction. Antiepileptic drugs are effective in the treatment of epilepsy to the extent that about 70% of people with epilepsy can be seizure-free, but poor adherence to medication is major problem to sustained remission and functional restoration. The aim of this study was to assess the prevalence and associated factors of antiepileptic drug nonadherence. Methods. Cross-sectional study was conducted on 450 individuals who were selected by systematic random sampling method. Antiepileptic drug nonadherence was measured by Morisky Medication Adherence Scale (MMAS) and logistic regression was used to look for significant associations. Result. The prevalence of AEDs nonadherence was 37.8%. Being on treatment for 6 years and above [AOR = 3.47, 95% CI: 1.88, 6.40], payment for AEDs [AOR = 2.76, 95% CI: 1.73, 4.42], lack of health information [AOR = 2.20, 95% CI: 1.41,3.43], poor social support [AOR = 1.88, 95%, CI: 1.01, 3.50], perceived stigma [AOR = 2.27, 95% CI: 1.45, 3.56], and experience side effect [AOR = 1.70, 95% CI: 1.06, 2.72] were significantly associated with antiepileptic drug nonadherence. Conclusion. More than one-third of people with epilepsy were not compliant with their AEDs. Giving health information about epilepsy and its management and consequent reduction in stigma will help for medication adherence.

show abstract

Section: Methodsmentioning

confidence: 99%

Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy

Getnet¹,

Woldeyohannes

Bekana³

et al. 2016

Behavioural Neurology

View full text Add to dashboard Cite

show abstract

“…It has fifteen items and a total score was calculated by addition of all item scores. The score above the value on 66th percentile of the data indicated presence of perceived/felt stigma [ 40 , 42 ]. Questions used to assess sociodemographic data and other relevant information were designed by the investigator.…”

Section: Methodsmentioning

confidence: 99%

Prevalence and Factors Associated with Perceived Stigma among Patients with Epilepsy in Ethiopia

Fanta¹,

Azale

Assefa³

et al. 2015

Psychiatry Journal

View full text Add to dashboard Cite

Background. Epilepsy stigma is considered to be one of the most important factors that have a negative influence on people with epilepsy. Among all types of stigma perceived stigma further exerts stress and restricts normal participation in society. Methods. Hospital based cross-sectional study was conducted from May 1, 2013, to May 30, 2013. All patients with epilepsy in Ethiopia were source population. The sample size was determined using single population proportion formula and 347 subjects were selected by using systematic random sampling method. Data was analyzed by using SPSS version 20. Results. A total of 346 participants with mean age of 29.3 ± 8.5 SD participated with a response rate of 99.7%. The prevalence of perceived stigma was 31.2%. Age range between 18 and 24 [AOR = 2.84, 95%CI: 1.02, 7.92], difficulty to attend follow-up because of stigma [AOR = 3.15, 95%CI: 1.19, 8.34], seizure related injury [AOR = 1.88, 95%CI: 1.12, 3.15], and contagion belief [AOR = 1.88, 95%CI: 1.10, 5.08] were significantly associated with perceived stigma. Conclusions. Perceived stigma was found to be a common problem among patients suffering from epilepsy. The results reinforce the need for creating awareness among patients with epilepsy and addressing misconceptions attached to epilepsy.

show abstract

Kilifi Epilepsy Education Program (KEEP): An intervention to reduce the epilepsy treatment gap

Cited by 2 publications

References 0 publications

Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy

Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy

Prevalence and Factors Associated with Perceived Stigma among Patients with Epilepsy in Ethiopia

Contact Info

Product

Resources

About